Friday, March 06, 2026

VivoSim Labs Appoints VP of Global Sales to Expand Biopharma Partnerships | NewsOut

Mar 5, 2026

Biotech and pharmaceutical investors: VivoSim Labs, a developer of next-generation methodologies for preclinical drug safety testing, has appointed Dr. Arumugam Rajhunitan as Vice President of Global Sales to accelerate commercial growth.

Reporting from the New York Stock Exchange, Jane King explains Dr. Rajhunitan will lead global sales expansion and partnerships with biopharma companies, pharmaceutical manufacturers, and research institutions, focusing on deploying VivoSim’s liver and gastrointestinal toxicity solutions to help identify drug safety risks earlier in the development process.

#VivoSimLabs
#DrugDevelopment
#PreclinicalTesting
#Biopharma
#PharmaceuticalResearch
#DrugSafety
#Toxicology
#BiotechInnovation
#LifeSciences
#HealthcareTechnology
#JaneKing
#NewsOut